23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Emily Ziedman

Senior Director, Program Management

Karyopharm Therapeutics

Boston, United States

9 profile visitsSpeakerSpeaker

About me

My organisation

Karyopharm Therapeutics

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).

Social media

Speaker sessions (2)

Wednesday, 16 October 2024

16:00 - 16:30

PANEL DISCUSSION: The art and science of decision-making in biotech

Format:In-personLocation:Beacon Hill Ballroom
  • Decision Analysis And Structured Decision Making

This panel discussion will address several approaches of different Pharma and Biotech companies to build a structured decision-making process.

Friday, 18 October 2024

15:00 - 16:00